Australia news live: eye health warning over GLP-1 drugs; victims of clergy abuse promised ‘full’ compensation by Christian Brothers | Australia news

Australia news live: eye health warning over GLP-1 drugs; victims of clergy abuse promised ‘full’ compensation by Christian Brothers | Australia news


www.theguardian.com

TGA warns of potential links between ‘rare but serious’ eye disorder and GLP-1 related drugs

Achol Arok

Australia’s peak medicines regulator has issued product warnings for several type 2 diabetes and obesity-related drugs over the potential to cause a “rare but severe” form of eye disorder.

The Therapeutic Goods Administration (TGA) warning concerns the GLP-1 RA class of medicines, currently marketed in Australia as Ozempic, Wegovy and Mounjaro.

The TGA says the eye disorder, non-arteritic anterior ischaemic optic neuropathy (NAION), may result in permanent visual impairment and there are no available treatments.

The regulator says it is aware of 36 reported cases of the eye disorder associated with the drugs.

Australian product information documents have been updated to reflect the new warning and patients prescribed the drugs are urged to “seek urgent medical attention if they experience sudden vision loss, including partial loss of vision”.

GLP-1 related drugs such as Ozempic have been linked to non-arteritic anterior ischaemic optic neuropathy.
GLP-1 related drugs such as Ozempic have been linked to non-arteritic anterior ischaemic optic neuropathy. Photograph: David J Phillip/AP
Share

Updated at 

Key events

Josh Taylor

Josh Taylor

Microsoft Teams outage resolved

Earlier we reported there was an outage for Microsoft’s meetings platform Teams, affecting users in the Asia Pacific region.

The company now reports the issue is resolved.

Share

Updated at 



Source link

Share this post :

Facebook
Twitter
LinkedIn
Pinterest

Leave a Reply

Your email address will not be published. Required fields are marked *

Create a new perspective on life

Your Ads Here (365 x 270 area)
Latest News
Categories

Subscribe our newsletter

Purus ut praesent facilisi dictumst sollicitudin cubilia ridiculus.